-+ 0.00%
-+ 0.00%
-+ 0.00%

AGOMAB RECEIVES U.S. PATENT FOR AGMB-447, ITS INHALED LUNG-RESTRICTED SMALL MOLECULE INHIBITOR OF ALK5 IN DEVELOPMENT FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

Reuters·03/26/2026 11:02:31

Please log in to view news